Table 2 Characteristics of the sample: compliance and prevalence
| Â | Self-reported compliance with last MDA treatment | Self-reported noncompliance with last MDA treatment |
|---|---|---|
High prevalence areas | 6 females; 5 males (11 total) | 4 females; 5 males (9 total) |
Low prevalence areas | 5 females; 7 males (12 total) | 7 females; 4 males (11 total) |